Spots Global Cancer Trial Database for Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
Official Title: A Phase IIb Randomized Study of Oral Seliciclib in Patients With Previously Treated Non-Small Cell Lung Cancer
Study ID: NCT00372073
Conditions
Study Description
Brief Summary: A phase 2 study to evaluate efficacy of oral seliciclib in treating non-small cell lung cancer (NSCLC).
Detailed Description: A randomized Phase II study of an experimental anti-cancer drug called seliciclib with objectives of evaluating safety and efficacy in patients with non-small cell lung cancer.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Cancer Center, Tucson, Arizona, United States
Pacific Coast Hematology Oncology Group, Fountain Valley, California, United States
Pasco Hernando Oncology, New Port Richey, Florida, United States
Rush University Medical Center, Chicago, Illinois, United States
The University of Chicago, Chicago, Illinois, United States
University of Maryland, Greenebaun Cancer Center, Baltimore, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Nebraska Medical Center, Omaha, Nebraska, United States
Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
VA Sierra Nevada Health Care System, Reno, Nevada, United States
New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States
Columbia Presbyterian Medical Center, New York, New York, United States
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
University of Pittsburg Cancer Institute, Pittsburgh, Pennsylvania, United States
The Family Cancer Center, Collierville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Southwest Regional Cancer Center, Austin, Texas, United States
Center for Oncology Research and Treatment, Dallas, Texas, United States
East Texas Medical Center, Tyler, Texas, United States
Danville Hematology Oncology, Danville, Virginia, United States
Contact Details
Name: Chandra Belani, M.D.
Affiliation: Milton S. Hershey Medical Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
